PRICE T ROWE ASSOCIATES INC /MD/
Position in NTLA — Intellia Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in NTLA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,830,670
+$733,998 QoQ
Shares Held
142,798
+17.1% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. NTLA ranks #142 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in NTLA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,830,670 | 142,798 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,096,672 | 121,988 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,597,664 | 92,511 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $479,636 | 51,134 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $312,171 | 43,906 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $458,179 | 39,295 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,971,031 | 582,532 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $27,862,181 | 1,244,959 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $44,705,152 | 1,625,051 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $55,923,019 | 1,834,143 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $64,796,335 | 2,049,220 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $84,026,822 | 2,060,491 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $69,685,991 | 1,869,761 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $67,315,195 | 1,929,355 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $97,217,069 | 1,737,260 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $105,969,852 | 2,047,331 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $161,318,025 | 2,219,871 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $248,345,147 | 2,100,348 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $314,519,772 | 2,344,538 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $402,587,757 | 2,486,491 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $186,551,944 | 2,324,490 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $115,376,035 | 2,120,883 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $28,985,139 | 1,458,005 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $28,446,660 | 1,353,314 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||